As on now, it is. But they are shifting to derivative and speciality sector. Theirt revenue from derivative and specilaity segment has increased from FY22 38% rev to FY23 50%. Moreover, they are focused on import substitution. Although they can’t command high marigin in derivative, if they execute their strategy well they can grow their MCAP. It’s my personal opinion though.
| Subscribe To Our Free Newsletter |
